Literature DB >> 28992720

Accuracy and Time Delay of Glucose Measurements of Continuous Glucose Monitoring and Bedside Artificial Pancreas During Hyperglycemic and Euglycemic Hyperinsulinemic Glucose Clamp Study.

Akio Kuroda1, Satoshi Taniguchi1, Yuko Akehi1, Hiroyasu Mori1, Motoyuki Tamaki1, Reiko Suzuki1, Yinhua Otsuka1, Munehide Matsuhisa1.   

Abstract

BACKGROUND: Glucose values of continuous glucose monitoring (CGM) have time delays compared with plasma glucose (PG) values. The artificial pancreas (STG-55, Nikkiso, Japan) (AP), which measures venous blood glucose directly, also has a time delay because of the long tubing lines from sampling vessel to the glucose sensor. We investigate accuracy and time delay of CGM and AP in comparison with PG values during 2-step glucose clamp study.
METHODS: Seven patients with type 2 diabetes and 2 healthy volunteers were included in this study. CGM (Enlite sensor, Medtronic, Northridge, CA, USA) was attached on the day before the experiment. Hyperglycemic (200 mg/dL) clamp was performed for 90 minutes, followed by euglycemic (100 mg/dL) hyperinsulinemic (100 μU/mL) clamp for 90-120 minutes using AP. CGM sensor glucose was calibrated just before and after the clamp study. AP and CGM values were compared with PG values.
RESULTS: AP values were significantly lower than PG values at 5, 30 minute during hyperglycemic clamp. In comparison, CGM value at 0 minute was significantly higher, and its following values were almost significantly lower than PG values. The time delay of AP and CGM values to reach maximum glucose levels were 5.0 ± 22.3 (NS) and 28.6 ± 32.5 ( P < .05) min, respectively. Mean absolute rate difference of CGM was significantly higher than AP (24.0 ± 7.6 vs 15.3 ± 4.6, P < .05) during glucose rising period (0-45 min); however, there were no significant differences during other periods.
CONCLUSIONS: Both CGM and AP failed to follow plasma glucose values during nonphysiologically rapid glucose rising, but indicated accurate values during physiological glucose change.

Entities:  

Keywords:  Parkes consensus error grid; artificial pancreas; continuous glucose monitoring; euglycemic hyperinsulinemic clamp study; hyperglycemic clamp study

Mesh:

Substances:

Year:  2017        PMID: 28992720      PMCID: PMC5951059          DOI: 10.1177/1932296817735122

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  14 in total

1.  Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?

Authors:  Teresa P Monsod; Daniel E Flanagan; Fran Rife; Rebecca Saenz; Sonia Caprio; Robert S Sherwin; William V Tamborlane
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

2.  Accuracy of the Sof-sensor glucose sensor with the iPro calibration algorithm.

Authors:  John B Welsh; Francine R Kaufman; Scott W Lee
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

3.  Evaluation of a novel continuous glucose measurement device in patients with diabetes mellitus across the glycemic range.

Authors:  Linda Morrow; Marcus Hompesch; Ann M Tideman; Jennifer Matson; Nancy Dunne; Scott Pardo; Joan L Parkes; Holly C Schachner; David A Simmons
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

Review 4.  Delays in minimally invasive continuous glucose monitoring devices: a review of current technology.

Authors:  D Barry Keenan; John J Mastrototaro; Gayane Voskanyan; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

5.  Impact of newly developed, next-generation artificial endocrine pancreas.

Authors:  Noriko Kambe; Shinji Kawahito; Naoji Mita; Kazumi Takaishi; Toshiko Katayama; Yoko Sakai; Tomohiro Soga; Hiroaki Kawano; Munehide Matsuhisa; Mitsuo Shimada; Tetsuya Kitagawa; Hiroshi Kitahata
Journal:  J Med Invest       Date:  2015

6.  Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor.

Authors:  Timothy S Bailey; Andrew Ahmann; Ronald Brazg; Mark Christiansen; Satish Garg; Elaine Watkins; John B Welsh; Scott W Lee
Journal:  Diabetes Technol Ther       Date:  2014-04-07       Impact factor: 6.118

7.  Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient.

Authors:  Shin-Ichi Gorogawa; Hideaki Kaneto; Munehide Matsuhisa; Kentaro Ohtoshi; Dan Kawamori; Yoji Hazama; Kazutomi Yoshiuchi; Yoshimitsu Yamasaki
Journal:  Diabetes Res Clin Pract       Date:  2004-12-08       Impact factor: 5.602

8.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

9.  Performance evaluations of continuous glucose monitoring systems: precision absolute relative deviation is part of the assessment.

Authors:  Karin Obermaier; Günther Schmelzeisen-Redeker; Michael Schoemaker; Hans-Martin Klötzer; Harald Kirchsteiger; Heino Eikmeier; Luigi del Re
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

10.  Time Delay of CGM Sensors: Relevance, Causes, and Countermeasures.

Authors:  Günther Schmelzeisen-Redeker; Michael Schoemaker; Harald Kirchsteiger; Guido Freckmann; Lutz Heinemann; Luigi Del Re
Journal:  J Diabetes Sci Technol       Date:  2015-08-04
View more
  5 in total

1.  Simple Post-Processing of Continuous Glucose Monitoring Measurements Improves Endpoints in Clinical Trials.

Authors:  Morten Hasselstrøm Jensen; Claus Dethlefsen; Ole Hejlesen; Peter Vestergaard
Journal:  J Diabetes Sci Technol       Date:  2019-05-16

2.  Associations of Triglyceride-Glucose Index and Its Derivatives with Hyperuricemia Risk: A Cohort Study in Chinese General Population.

Authors:  Qing Gu; Xue Hu; Jian Meng; Jun Ge; Sui Jun Wang; Xing Zhen Liu
Journal:  Int J Endocrinol       Date:  2020-09-17       Impact factor: 3.257

3.  Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.

Authors:  Morten Hasselstrøm Jensen; Peter Vestergaard; Irl B Hirsch; Ole Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2020-09-18

Review 4.  Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care.

Authors:  Timothy Valk; Carol McMorrow
Journal:  SAGE Open Med       Date:  2020-11-19

5.  How to Achieve Sufficient Endogenous Insulin Suppression in Euglycemic Clamps Assessing the Pharmacokinetics and Pharmacodynamics of Long-Acting Insulin Preparations Employing Healthy Volunteers.

Authors:  Hui Liu; Ting Li; Hongling Yu; Jiaqi Li; Huiwen Tan; Yerong Yu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.